了解全身性硬化症中胃肠道微生物群:方法学的进步和新兴的研究研究
Alana J Haussmann1, Zsuzsanna H McMahan2, Elizabeth R Volkmann1
1Department of Medicine, University of California, Los Angeles, David Geffen School of Medicine.
Current opinion in rheumatology
|August 27, 2024
概括
肠道微生物组的改变,称为失生症,与系统性硬化症 (SSc) 的特定症状有关. 先进的研究和针对肠道疾病的新疗法为管理SSc进展提供了潜力.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物组研究 微生物组研究
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病.
- 胃肠道 (GI) 微生物组在免疫系统调节和整体健康方面发挥着至关重要的作用.
- 新出现的证据表明,胃肠道失调症和SSc病原体之间存在显著联系.
研究的目的:
- 审查肠道微生物组在SSc.中的作用.
- 描述评估人类肠道肠道微生物组的方法.
- 探索肠道失调和SSc临床表现之间的联系.
- 讨论针对SSc相关的肠道肠道微生物群的新兴治疗策略.
主要方法:
- 评论最近的科学文献.
- 描述先进的胃肠道微生物组分析技术 (例如,猎枪元基因组学,元转录组学).
- 对研究的分析,这些研究将肠道肠道微生物群的特征与SSc的临床特征联系起来.
主要成果:
- 失生症在SSc患者中普遍存在,并与特定的临床特征相关,例如间歇性肺部疾病.
- 先进的分子技术为SSc中的微生物组成和功能提供了详细的见解.
- 在SSc患者中观察到独特的胃肠道微生物组概况,具有明显的临床表现.
结论:
- 胃肠道失调症是SSc.中与特定临床特征相关的重要因素.
- 新的工具增强了对失生症,SSc及其并发症之间的关系的理解.
- 针对胃肠道微生物群的治疗干预,包括饮食,益生菌,抗生素和便微生物群移植,对SSc管理和预防有希望.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...


